Bone Medical Limited Share Price Australian S.E.
Equities
AU0000BNEDC4
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- AUD | - |
03:53am | Botanix Pharmaceuticals to Raise AU$70 Million via Institutional Placement | MT |
06-20 | Botanix Pharmaceuticals Secures US FDA Approval for Topical Medication | MT |
Sales 2024 * | 800M 533M 42.13B | Sales 2025 * | 30.5B 20.34B 1,606B | Capitalization | 528M 352M 27.79B |
---|---|---|---|---|---|
Net income 2024 * | -11.7B -7.8B -616B | Net income 2025 * | 9.3B 6.2B 490B | EV / Sales 2024 * | -11.3 x |
Net cash position 2024 * | 9.6B 6.4B 506B | Net cash position 2025 * | 2.3B 1.53B 121B | EV / Sales 2025 * | -0.06 x |
P/E ratio 2024 * |
-33.5
x | P/E ratio 2025 * |
33.5
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.28% |
Managers | Title | Age | Since |
---|---|---|---|
Howie McKibbon
CEO | Chief Executive Officer | - | 30/04/19 |
Vincent Ippolito
CHM | Chairman | 65 | 19/05/19 |
Chief Tech/Sci/R&D Officer | 68 | 28/02/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stewart Washer
BRD | Director/Board Member | 54 | 20/02/19 |
Henry Bosch
BRD | Director/Board Member | - | 30/06/16 |
Vincent Ippolito
CHM | Chairman | 65 | 19/05/19 |
1st Jan change | Capi. | |
---|---|---|
+15.61% | 76.49B | |
-23.51% | 4.39B | |
+30.92% | 4.19B | |
+13.52% | 4.13B | |
+8.44% | 2.16B | |
-31.43% | 2.07B | |
+7.46% | 1.96B | |
-45.87% | 1.72B | |
-0.50% | 1.64B |